English
简体中文
Total: £ 56.28
2026-04-10 | Pages: 103 | Tables: 108
The global Mitogen-Activated Protein Kinase (MAPK) Inhibitors Therapeutics market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Mitogen-Activated Prote...
2026-04-10 | Pages: 152 | Tables: 147
The global Decentralized Clinical Trial Solution market was valued at US$ 8611 million in 2025 and is anticipated to reach US$ 17480 million by 2032, at a CAGR of 10.8% from 2026 to 2032.A Decentralized Clinical Trial (DCT) solution refers to a metho...
2026-04-10 | Pages: 115 | Tables: 113
The global Rare Disease Enzyme Replacement Therapy Drugs market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Rare disease enzyme replacement therapy drugs are specialized pharmaceu...
2026-04-10 | Pages: 103 | Tables: 109
The global Oncology Clinical Trial Monitor market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Oncology Clinical Trial Monitor is projected to increas...
2026-04-10 | Pages: 140 | Tables: 133
The global Rare Biomarkers market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Rare Biomarkers is projected to increase from US$ million in 2025 to US...
2026-04-10 | Pages: 90 | Tables: 97
The global Drug Desensitization market was valued at US$ 717 million in 2025 and is anticipated to reach US$ 1236 million by 2032, at a CAGR of 8.2% from 2026 to 2032.The North American market for Drug Desensitization is projected to increase from US...
2026-04-10 | Pages: 120 | Tables: 114
The global Photosensitizers for Photodynamic Therapy market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Photosensitizers for photodynamic therapy are light-sensitive compounds or ...
2026-04-10 | Pages: 115 | Tables: 113
The global Photodynamic Therapy Drugs (PTD) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Photodynamic therapy drugs (PTD) are photosensitizing agents used in photodynamic th...
2026-04-10 | Pages: 113 | Tables: 120
The global Perioperative Anaesthesia Information Management Systems market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Perioperative Anaesthesia Information Management Systems is ...
2026-04-10 | Pages: 124 | Tables: 122
The global Human Neural Stem Cell Media market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic la...
2026-04-10 | Pages: 119 | Tables: 119
The global Neural Stem Cell Media and Reagents market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Neural stem cells are multipotent precursors defined by their capacity for self-r...
2026-04-10 | Pages: 126 | Tables: 125
The global Neural Stem Cell Media market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscap...
2026-08-30 | Pages: 114 | Tables: 119
The global Immunohematology market was valued at US$ 2562 million in 2025 and is anticipated to reach US$ 3418 million by 2032, at a CAGR of 4.6% from 2026 to 2032.Commercially, immunohematology usually refers to pre-transfusion compatibility testing...
2026-08-29 | Pages: 113 | Tables: 117
The global Pulse-chase Analysis market was valued at US$ 818 million in 2025 and is anticipated to reach US$ 1488 million by 2032, at a CAGR of 8.9% from 2026 to 2032.Pulse-chase Analysis is a classic experimental method in cells or biological system...
2026-08-29 | Pages: 114 | Tables: 112
The global Dengue Rapid Test market was valued at US$ 626 million in 2025 and is anticipated to reach US$ 952 million by 2032, at a CAGR of 6.3% from 2026 to 2032.Dengue Rapid Test is an in vitro diagnostic (IVD) product based on immunochromatography...
